Dauntless Pharmaceuticals

12390 El Camino Real
Suite 170
San Diego
California
92130
United States

Tel: 858-999-3053

Show jobs for this employer

About Dauntless Pharmaceuticals

Dauntless provides a better way to develop drugs.
The traditional biotech company holds numerous assets at various stages of development, and its investors, management, labs, and staff collectively share interest in all company assets. In contrast, Dauntless uses a one-asset, one-company model. Each asset is held in a separate holding company, with Dauntless managing the development of each asset and employing expert consultants who specialize in the unique requirements of a given asset. This innovative approach facilitates operational efficiency, drug development speed, and a simplified business development structure. The result: lower costs, shorter timelines, higher returns.
YEAR FOUNDED:
2015
LEADERSHIP:
President and CEO: Joel F. Martin, PhD
Vice President, Development: Olivier Laurent, PhD
Vice President, Regulatory Affairs and Quality: Michelle Mazzoni, PhD, RAC
Director of Clinical Operations: Mark Daniels
PIPELINE:
Please click here for Dauntless' pipeline.

3 articles about Dauntless Pharmaceuticals